FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Irving Nachamkin

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Lenora Codrington; Jennifer Han; Baofeng Hu; Danica Kuncio; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Yield of methicillin-resistant Staphylococcus aureus on moist swabs versus dry swabs.
Rachel M Greenblatt; Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.
Jennifer H Han; Baofeng Hu; Susan E Coffin; Neil O Fishman; Darren R Linkin; Irving Nachamkin; Pam Tolomeo; Mark G Weiner; Theoklis E Zaoutis; Ebbing Lautenbach
Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Irving Nachamkin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lenora Codrington; Jennifer Han; Baofeng Hu; Danica Kuncio; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Yield of methicillin-resistant Staphylococcus aureus on moist swabs versus dry swabs.
American journal of infection control 2013;41(5):469-70.
2013: Rachel M Greenblatt; Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2013;34(1):40-8.
2012: Jennifer H Han; Baofeng Hu; Susan E Coffin; Neil O Fishman; Darren R Linkin; Irving Nachamkin; Pam Tolomeo; Mark G Weiner; Theoklis E Zaoutis; Ebbing Lautenbach
Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2012;33(12):1242-5.
2012: Nkuchia M M'ikanatha; Amanda Perry; Stanley M Reynolds; Paul Rogers; Lisa A Dettinger; Irving Nachamkin
Culturing stool specimens for Campylobacter spp., Pennsylvania, USA.
Emerging infectious diseases 2012;18(3):484-7.
2012: Zhenying Liu; Paul H Edelstein; Ebbing Lautenbach; Irving Nachamkin; Joshua P Metlay
Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era.
Antimicrobial agents and chemotherapy 2012;56(2):743-50.
2012: Kathleen T Montone; James Palmer; Alexander G Chiu; Michael D Feldman; David W Kennedy; Donald C Lanza; Virginia A LiVolsi; Laurie A Loevner; Irving Nachamkin
Fungal rhinosinusitis: a retrospective microbiologic and pathologic review of 400 patients at a single university medical center.
International journal of otolaryngology 2012;2012():684835.
2011: Kathleen T Montone; James Palmer; Alexander G Chiu; Michael D Feldman; David W Kennedy; Donald C Lanza; Virginia A LiVolsi; Irving Nachamkin
Rapid In-situ hybridization for dematiaceous fungi using a broad-spectrum oligonucleotide DNA probe.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2011;20(3):180-3.
2011: Kathleen T Montone; Virginia A LiVolsi; Donald C Lanza; David W Kennedy; James Palmer; Alexander G Chiu; Michael D Feldman; Laurie A Loevner; Irving Nachamkin
In situ hybridization for specific fungal organisms in acute invasive fungal rhinosinusitis.
American journal of clinical pathology 2011;135(2):190-9.
2010: Ingi Lee; Knashawn H Morales; Theoklis E Zaoutis; Neil O Fishman; Irving Nachamkin; Ebbing Lautenbach
Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.
American journal of infection control 2010;38(9):740-5.
2010: Ebbing Lautenbach; Joshua P Metlay; Xiangqun Mao; Xiaoyan Han; Neil O Fishman; Warren B Bilker; Pam Tolomeo; Mary Wheeler; Irving Nachamkin
The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(3):280-5.
2010: Ingi Lee; Theoklis E Zaoutis; Neil O Fishman; Knashawn H Morales; Irving Nachamkin; Ebbing Lautenbach
Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: potential impact of control group selection on characterizing the association between previous fluconazole use and fluconazole resistance.
American journal of infection control 2010;38(6):456-60.
2010: Kathleen T Montone; Leslie A Litzky; Michael D Feldman; Heather Peterman; Benjamin Mathis; Jeffrey Baliff; Larry R Kaiser; John C Kucharczuk; Irving Nachamkin
In situ hybridization for Coccidioides immitis 5.8S ribosomal RNA sequences in formalin-fixed, paraffin-embedded pulmonary specimens using a locked nucleic acid probe: a rapid means for identification in tissue sections.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2010;19(2):99-104.
2010: Ebbing Lautenbach; Pam Tolomeo; Irving Nachamkin; Baofeng Hu; Theoklis E Zaoutis
The impact of household transmission on duration of outpatient colonization with methicillin-resistant Staphylococcus aureus.
Epidemiology and infection 2010;138(5):683-5.
2009: Shannon E McGettigan; Baofeng Hu; Kathleen Andreacchio; Irving Nachamkin; Paul H Edelstein
Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania.
Journal of clinical microbiology 2009;47(9):2970-4.
2009: Eline T Luning Prak; Donald S Young; Malek Kamoun; Irving Nachamkin; C Bruce Alexander; Steven L Spitalnik; Ellinor I B Peerschke; Brian R Smith
2008 ACLPS panel discussion on resident education in clinical pathology.
American journal of clinical pathology 2009;131(5):618-22.
2009: Ebbing Lautenbach; Irving Nachamkin; Baofeng Hu; Neil O Fishman; Pam Tolomeo; Priya Prasad; Warren B Bilker; Theoklis E Zaoutis
Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2009;30(4):380-2.
2009: Ingi Lee; Neil O Fishman; Theoklis E Zaoutis; Knashawn H Morales; Mark G Weiner; Marie Synnestvedt; Irving Nachamkin; Ebbing Lautenbach
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections.
Archives of internal medicine 2009;169(4):379-83.
2008: Irving Nachamkin; Sean V Shadomy; Anthony P Moran; Nancy Cox; Collette Fitzgerald; Huong Ung; Adrian T Corcoran; John K Iskander; Lawrence B Schonberger; Robert T Chen
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome.
The Journal of infectious diseases 2008;198(2):226-33.
2008: Deborah B Nelson; Scarlett Bellamy; Irving Nachamkin; Althea Ruffin; Lynne Allen-Taylor; Frank K Friedenberg
Characteristics and pregnancy outcomes of pregnant women asymptomatic for bacterial vaginosis.
Maternal and child health journal 2008;12(2):216-22.
2008: Jason Y Kim; Ebbing Lautenbach; Jaclyn Chu; Monika Goyal; Irving Nachamkin; Karin L McGowan; Susan E Coffin; Theoklis E Zaoutis
Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species.
American journal of infection control 2008;36(1):70-3.
2007: Deborah B Nelson; Scarlett Bellamy; Irving Nachamkin; Roberta B Ness; George A Macones; Lynne Allen-Taylor
First trimester bacterial vaginosis, individual microorganism levels, and risk of second trimester pregnancy loss among urban women.
Fertility and sterility 2007;88(5):1396-403.
2007: Deborah B Nelson; Scarlett Bellamy; A Odibo; Irving Nachamkin; Roberta B Ness; Lynne Allen-Taylor
Vaginal symptoms and bacterial vaginosis (BV): how useful is self-report? Development of a screening tool for predicting BV status.
Epidemiology and infection 2007;135(8):1369-75.
2007: Irving Nachamkin; P Arzarte Barbosa; P Arzate Barbosa; Huong Ung; H Ung; C Lobato; A Gonzalez Rivera; A Gonzalez Rivera; P Rodriguez; A Garcia Briseno; A Garcia Briseno; L Maria Cordero; L Garcia Perea; L Garcia Perea; J Carlos Perez; M Ribera; P Chico Aldama; G Dávila Guitérrez; L Flores Sarnat; M Ruiz García; Jean Veitch; C Fitzgerald; David R Cornblath; D Cornblath; M Rodriguez Pinto; M Rodriguez Pinto; John W Griffin; Hugh J Willison; Arthur K Asbury; Guy M McKhann
Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
Neurology 2007;69(17):1665-71.
2007: Leanne B Gasink; Neil O Fishman; Irving Nachamkin; Warren B Bilker; Ebbing Lautenbach
Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2007;28(10):1175-80.
2007: Viraj N Perera; Irving Nachamkin; Huong Ung; John H Patterson; Malcolm J McConville; Peter J Coloe; Benjamin N Fry
Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.
FEMS immunology and medical microbiology 2007;50(1):27-36.
2007: John B Hye; Irving Nachamkin
Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Neurology 2007;68(19):1633-4.
2007: James R Treat; William D James; Irving Nachamkin; John T Seykora
Growth inhibition of Trichophyton species by Pseudomonas aeruginosa.
Archives of dermatology 2007;143(1):61-4.
2007: Zhuolin Han; Ebbing Lautenbach; Neil O Fishman; Irving Nachamkin
Evaluation of mannitol salt agar, CHROMagar Staph aureus and CHROMagar MRSA for detection of meticillin-resistant Staphylococcus aureus from nasal swab specimens.
Journal of medical microbiology 2007;56(Pt 1):43-6.
2006: Ebbing Lautenbach; Pam Tolomeo; Xiangqun Mao; Neil O Fishman; Joshua P Metlay; Warren B Bilker; Irving Nachamkin
Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital.
Antimicrobial agents and chemotherapy 2006;50(11):3939-43.
2006: Ebbing Lautenbach; Mark G Weiner; Irving Nachamkin; Warren B Bilker; Angela Sheridan; Neil O Fishman
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(9):893-900.
2006: John Pape; Jill Wadlin; Irving Nachamkin
Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures.
Journal of clinical microbiology 2006;44(7):2575-6.
2006: Shawn Binkley; Neil O Fishman; Lori A LaRosa; Ann Marie Marr; Irving Nachamkin; David Wordell; Warren B Bilker; Ebbing Lautenbach
Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(7):682-7.
2006: Ebbing Lautenbach; Neil O Fishman; Joshua P Metlay; Xiangqun Mao; Warren B Bilker; Pam Tolomeo; Irving Nachamkin
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
The Journal of infectious diseases 2006;194(1):79-85.
2006: Svenja J Albrecht; Neil O Fishman; Jennifer Kitchen; Irving Nachamkin; Warren B Bilker; Cindy Hoegg; Carol Samel; Stephanie Barbagallo; Judy Arentzen; Ebbing Lautenbach
Reemergence of gram-negative health care-associated bloodstream infections.
Archives of internal medicine 2006;166(12):1289-94.
2006: Leanne B Gasink; Neil O Fishman; Mark G Weiner; Irving Nachamkin; Warren B Bilker; Ebbing Lautenbach
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact.
The American journal of medicine 2006;119(6):526.e19-25.
2006: Eline T Luning Prak; Jason Young Park; Gordon Yu; Irving Nachamkin
Point: developing a curriculum in clinical pathology.
Clinical chemistry 2006;52(6):969-71.
2006: Mari Mizuta; Darren R Linkin; Irving Nachamkin; Neil O Fishman; Mark G Weiner; Angela Sheridan; Ebbing Lautenbach
Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(4):413-5.
2006: Ebbing Lautenbach; Irving Nachamkin
Analysis and presentation of cumulative antimicrobial susceptibility data (antibiograms): substantial variability across medical centers in the United States.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(4):409-12.
2006: Adam D Lipworth; Emily P Hyle; Neil O Fishman; Irving Nachamkin; Warren B Bilker; Ann Marie Marr; Lori A LaRosa; Nishaminy Kasbekar; Ebbing Lautenbach
Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(3):279-86.
2005: Emily P Hyle; Adam D Lipworth; Theoklis E Zaoutis; Irving Nachamkin; Warren B Bilker; Ebbing Lautenbach
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection.
Archives of internal medicine 2005;165(12):1375-80.
2005: Emily P Hyle; Adam D Lipworth; Theoklis E Zaoutis; Irving Nachamkin; Neil O Fishman; Warren B Bilker; Xiangquin Mao; Ebbing Lautenbach
Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(9):1317-24.
2005: Theoklis E Zaoutis; Monika Goyal; Jaclyn H Chu; Susan E Coffin; Louis M Bell; Irving Nachamkin; Karin L McGowan; Warren B Bilker; Ebbing Lautenbach
Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
Pediatrics 2005;115(4):942-9.
2005: Ebbing Lautenbach; Anthony D Harris; Eli N Perencevich; Irving Nachamkin; Pam Tolomeo; Joshua P Metlay
Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.
Antimicrobial agents and chemotherapy 2005;49(2):798-800.
2004: Ebbing Lautenbach; Russell Localio; Irving Nachamkin
Clinicians required very high sensitivity of a bacteremia prediction rule.
Journal of clinical epidemiology 2004;57(10):1104-6.
2004: Kimberly Dumoff; Paul C McGovern; Paul H Edelstein; Irving Nachamkin
Legionella maceachernii pneumonia in a patient with HIV infection.
Diagnostic microbiology and infectious disease 2004;50(2):141-5.
2004: Richard W Snyder; Jorg Ruhe; Sidney Kobrin; Alan G Wasserstein; Christa Doline; Irving Nachamkin; Joshua H Lipschutz
Asaia bogorensis peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(2):e15-7.
2004: Jean B Patel; Richard J Wallace; Barbara A Brown-Elliott; Tony Taylor; Carol Imperatrice; Deborah G B Leonard; Rebecca W Wilson; Linda Mann; Kenneth C Jost; Irving Nachamkin
Sequence-based identification of aerobic actinomycetes.
Journal of clinical microbiology 2004;42(6):2530-40.
2004: Elizabeth Cerceo; Jason D Christie; Irving Nachamkin; Ebbing Lautenbach
Central nervous system infections due to Abiotrophia and Granulicatella species: an emerging challenge?
Diagnostic microbiology and infectious disease 2004;48(3):161-5.
2004: Ebbing Lautenbach; Brian L Strom; Irving Nachamkin; Warren B Bilker; Ann Marie Marr; Lori A LaRosa; Neil O Fishman
Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(5):655-62.
2004: Ebbing Lautenbach; Carolyn V Gould; Lori A LaRosa; Ann Marie Marr; Irving Nachamkin; Warren B Bilker; Neil O Fishman
Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates.
International journal of antimicrobial agents 2004;23(2):200-3.
2004: Carolyn V Gould; Neil O Fishman; Irving Nachamkin; Ebbing Lautenbach
Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: impact of prior fluoroquinolone use?
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(2):138-45.
2004: Edward E Leonard; Lucy S Tompkins; Stanley Falkow; Irving Nachamkin
Comparison of Campylobacter jejuni isolates implicated in Guillain-Barré syndrome and strains that cause enteritis by a DNA microarray.
Infection and immunity 2004;72(2):1199-203.
2003: Deborah B Nelson; Scarlett Bellamy; Terri S Gray; Irving Nachamkin
Self-collected versus provider-collected vaginal swabs for the diagnosis of bacterial vaginosis: an assessment of validity and reliability.
Journal of clinical epidemiology 2003;56(9):862-6.
2003: Vincent Lo Re; Neil O Fishman; Irving Nachamkin
Recurrent catheter-related Rhodotorula rubra infection.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(8):897-900.
2003: Eleni E Magira; Miltiadis Papaioakim; Irving Nachamkin; Arthur K Asbury; Chun Y Li; Ho W Tony; John W Griffin; Guy M McKhann; Dimitri S Monos
Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(6):3074-80.
2003: Ebbing Lautenbach; Lori A LaRosa; Ann Marie Marr; Irving Nachamkin; Warren B Bilker; Neil O Fishman
Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(4):440-6.
2002: Irving Nachamkin; Huong Ung; Ming Li
Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982-2001.
Emerging infectious diseases 2002;8(12):1501-3.
2002: Michelle Paessler; Arnold I Levinson; Jean B Patel; Mindy Schuster; Melanie Minda; Irving Nachamkin
Disseminated Mycoplasma orale infection in a patient with common variable immunodeficiency syndrome.
Diagnostic microbiology and infectious disease 2002;44(2):201-4.
2002: Irving Nachamkin; Jirong Liu; Ming Li; Huong Ung; Anthony P Moran; Martina M Prendergast; Kazim A Sheikh
Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.
Infection and immunity 2002;70(9):5299-303.
2002: Irving Nachamkin
Rabbit model of Guillain-Barré syndrome.
Annals of neurology 2002;52(1):127-8; author reply 128-9.
2002: Irving Nachamkin
Chronic effects of Campylobacter infection.
Microbes and infection / Institut Pasteur 2002;4(4):399-403.
2001: Vincent Lo Re; Patrick J Brennan; Jill Wadlin; Ransom Weaver; Irving Nachamkin
Infected branchial cleft cyst due to Bordetella bronchiseptica in an immunocompetent patient.
Journal of clinical microbiology 2001;39(11):4210-2.
2001: Irving Nachamkin; Jørgen Engberg; Michaela Gutacker; R J Meinersman; Chun Y Li; P Arzate; E Teeple; Vivian Fussing; Ho W Tony; Arthur K Asbury; John W Griffin; Guy M McKhann; Jean-Claude Piffaretti
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis.
The Journal of infectious diseases 2001;184(2):221-6.
2001: Jørgen Engberg; Irving Nachamkin; Vivian Fussing; Guy M McKhann; John W Griffin; Jean-Claude Piffaretti; Eva Møller Nielsen; Peter Gerner-Smidt
Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis.
The Journal of infectious diseases 2001;184(2):215-20.
2001: Richard L Guerrant; Thomas J Van Gilder; Theodore S Steiner; Nathan M Thielman; L Slutsker; R V Tauxe; T Hennessy; Patricia M Griffin; H DuPont; RICHARD SACK; P Tarr; Marguerite A Neill; Irving Nachamkin; L B Reller; Michael Osterholm; Michael Bennish; L K Pickering
Practice guidelines for the management of infectious diarrhea.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(3):331-51.
2001: Irving Nachamkin; Nicholas J Panaro; Ming Li; Huong Ung; PK Yuen; Larry J Kricka; Peter Wilding
Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene.
Journal of clinical microbiology 2001;39(2):754-7.
2001: Jørgen Engberg; Frank M Aarestrup; D E Taylor; Peter Gerner-Smidt; Irving Nachamkin
Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
Emerging infectious diseases 2001;7(1):24-34.
2001: Jean B Patel; A M Donahue; Irving Nachamkin
Performance of two rapid, single-use immunoassays for the detection of Clostridium difficile toxin A.
Diagnostic microbiology and infectious disease 2001;39(1):21-4.
2000: Michiko Watari; Hidemichi Watari; Irving Nachamkin; Jerome F Strauss
Lipopolysaccharide induces expression of genes encoding pro-inflammatory cytokines and the elastin-degrading enzyme, cathepsin S, in human cervical smooth-muscle cells.
Journal of the Society for Gynecologic Investigation 2000;7(3):190-8.
2000: Jean B Patel; D G Leonard; X Pan; J M Musser; R E Berman; Irving Nachamkin
Sequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA bacterial identification system.
Journal of clinical microbiology 2000;38(1):246-51.
1999: P Arzate Barbosa; R Garcia Gonzalez; E Ponce Nava; Irving Nachamkin
Comparison of two selective media for the isolation of Campylobacter species from a pediatric population in Mexico.
Diagnostic microbiology and infectious disease 1999;34(4):329-32.
1999: Jean B Patel; Jill E Clarridge; M S Schuster; M Waddington; J Osborne; Irving Nachamkin
Bacteremia caused by a novel isolate resembling leptotrichia species in a neutropenic patient.
Journal of clinical microbiology 1999;37(6):2064-7.
1999: Jill Wadlin; G Hanko; R Stewart; J Pape; Irving Nachamkin
Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory.
Journal of clinical microbiology 1999;37(6):1967-70.
1999: Irving Nachamkin; Huong Ung; A P Moran; D Yoo; M M Prendergast; M A Nicholson; Kazim A Sheikh; Ho W Tony; Arthur K Asbury; Guy M McKhann; John W Griffin
Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
The Journal of infectious diseases 1999;179(5):1183-9.
1999: Ho W Tony; Hugh J Willison; Irving Nachamkin; Chun Y Li; Jean Veitch; Huong Ung; G R Wang; R C Liu; David R Cornblath; Arthur K Asbury; John W Griffin; Guy M McKhann
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.
Annals of neurology 1999;45(2):168-73.
1998: Kazim A Sheikh; Irving Nachamkin; Ho W Tony; Hugh J Willison; Jean Veitch; Huong Ung; M Nicholson; Chun Y Li; HS Wu; B Q Shen; David R Cornblath; Arthur K Asbury; Guy M McKhann; John W Griffin
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility.
Neurology 1998;51(2):371-8.
1998: Irving Nachamkin; B M Allos; Ho W Tony
Campylobacter species and Guillain-Barré syndrome.
Clinical microbiology reviews 1998;11(3):555-67.
1998: Kazim A Sheikh; Ho W Tony; Irving Nachamkin; Chun Y Li; David R Cornblath; Arthur K Asbury; John W Griffin; Guy M McKhann
Molecular mimicry in Guillain-Barré syndrome.
Annals of the New York Academy of Sciences 1998;845():307-21.
1997: Irving Nachamkin
Microbiologic approaches for studying Campylobacter species in patients with Guillain-Barré syndrome.
The Journal of infectious diseases 1997;176 Suppl 2():S106-14.
1997: M Schuster; Martin Blaser; Irving Nachamkin
Serendipitous detection of persistent Campylobacter jejuni subspecies jejuni bacteremia in a patient undergoing bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(6):1270.
1997: Irving Nachamkin; C Kang; M P Weinstein
Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):894-900.
1997: Ho W Tony; Sung-Tsang Hsieh; Irving Nachamkin; Hugh J Willison; Kazim A Sheikh; Julia Kiehlbauch; K Flanigan; justin charles mcarthur; David R Cornblath; Guy M McKhann; John W Griffin
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.
Neurology 1997;48(3):717-24.
1996: John Hines; Irving Nachamkin
Effective use of the clinical microbiology laboratory for diagnosing diarrheal diseases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(6):1292-301.
1996: A Waegel; Irving Nachamkin
Detection and molecular typing of Campylobacter jejuni in fecal samples by polymerase chain reaction.
Molecular and cellular probes 1996;10(2):75-80.
1996: Irving Nachamkin; Huong Ung; C M Patton
Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system.
Journal of clinical microbiology 1996;34(2):277-81.
1995: S Rhoads; L Marinelli; C A Imperatrice; Irving Nachamkin
Comparison of MicroScan WalkAway system and Vitek system for identification of gram-negative bacteria.
Journal of clinical microbiology 1995;33(11):3044-6.
1994: Irving Nachamkin; S H Fischer; X H Yang; O Benitez; A Cravioto
Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk.
Epidemiology and infection 1994;112(2):359-65.
1993: Irving Nachamkin; K Bohachick; C M Patton
Flagellin gene typing of Campylobacter jejuni by restriction fragment length polymorphism analysis.
Journal of clinical microbiology 1993;31(6):1531-6.
1993: Irving Nachamkin; X H Yang; N J Stern
Role of Campylobacter jejuni flagella as colonization factors for three-day-old chicks: analysis with flagellar mutants.
Applied and environmental microbiology 1993;59(5):1269-73.
1993: C A Imperatrice; Irving Nachamkin
Evaluation of the Vitek EPS enteric pathogen screen card for detecting Salmonella, Shigella, and Yersinia spp.
Journal of clinical microbiology 1993;31(2):433-5.
1992: Mark S Lachs; Irving Nachamkin; P H Edelstein; J Goldman; Alvan R Feinstein; J S Schwartz
Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection.
Annals of internal medicine 1992;117(2):135-40.
1992: Irving Nachamkin; R R MacGregor; J L Staneck; A Y Tsang; J C Denner; M Willner; S Barbagallo
Niacin-positive Mycobacterium kansasii isolated from immunocompromised patients.
Journal of clinical microbiology 1992;30(5):1344-6.
1992: Irving Nachamkin; X H Yang
Local immune responses to the Campylobacter flagellin in acute Campylobacter gastrointestinal infection.
Journal of clinical microbiology 1992;30(2):509-11.
1991: S H Fischer; Irving Nachamkin
Common and variable domains of the flagellin gene, flaA, in Campylobacter jejuni.
Molecular microbiology 1991;5(5):1151-8.
1990: M E Aguero-Rosenfeld; X H Yang; Irving Nachamkin
Infection of adult Syrian hamsters with flagellar variants of Campylobacter jejuni.
Infection and immunity 1990;58(7):2214-9.
1990: Fred C Tenover; L Carlson; S Barbagallo; Irving Nachamkin
DNA probe culture confirmation assay for identification of thermophilic Campylobacter species.
Journal of clinical microbiology 1990;28(6):1284-7.
1990: Irving Nachamkin; S Barbagallo
Culture confirmation of Campylobacter spp. by latex agglutination.
Journal of clinical microbiology 1990;28(4):817-8.
1990: Don L Siegel; P H Edelstein; Irving Nachamkin
Inappropriate testing for diarrheal diseases in the hospital.
JAMA : the journal of the American Medical Association 1990;263(7):979-82.
1989: M C Harris; C Deuber; Richard A Polin; Irving Nachamkin
Investigation of apparent false-positive urine latex particle agglutination tests for the detection of group B streptococcus antigen.
Journal of clinical microbiology 1989;27(10):2214-7.
1989: Irving Nachamkin; X H Yang
Human antibody response to Campylobacter jejuni flagellin protein and a synthetic N-terminal flagellin peptide.
Journal of clinical microbiology 1989;27(10):2195-8.
1988: J Metzler; Irving Nachamkin
Evaluation of a latex agglutination test for the detection of Salmonella and Shigella spp. by using broth enrichment.
Journal of clinical microbiology 1988;26(12):2501-4.
1988: R A Ciotti; Steven J Sondheimer; Irving Nachamkin
Detecting Chlamydia trachomatis by direct immunofluorescence using a Cytobrush sampling technique.
Genitourinary medicine 1988;64(4):245-6.
1988: T Rappaport; K P Sawyer; Irving Nachamkin
Evaluation of several commercial biochemical and immunologic methods for rapid identification of gram-positive cocci directly from blood cultures.
Journal of clinical microbiology 1988;26(7):1335-8.
1988: Irving Nachamkin; P Axelrod; George H Talbot; S H Fischer; Christine Wennersten; R C Moellering; R R MacGregor
Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospital.
Journal of clinical microbiology 1988;26(7):1287-91.
1988: Irving Nachamkin; G Gibson; K Sawyer; C Samel; D Skalina
In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
Diagnostic microbiology and infectious disease 1988;9(2):87-96.
1987: Irving Nachamkin; K Sawyer; D Skalina; G W Crooks; R Ciotti; Steven J Sondheimer
Test-of-cure analysis by direct immunofluorescence for Chlamydia trachomatis after antimicrobial therapy.
Journal of clinical microbiology 1987;25(9):1774-5.
1986: Irving Nachamkin; A M Hart
Common and specific epitopes of Campylobacter flagellin recognized by monoclonal antibodies.
Infection and immunity 1986;53(2):438-40.
1986: Irving Nachamkin; L Lotz-Nolan; D Skalina
Evaluation of a commercial cytotoxicity assay for detection of Clostridium difficile toxin.
Journal of clinical microbiology 1986;23(5):954-5.
1985: Irving Nachamkin; A M Hart
Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection.
Journal of clinical microbiology 1985;21(1):33-8.
1984: Irving Nachamkin; C Stowell; D Skalina; A M Jones; R M Hoop; R M Smibert
Campylobacter laridis causing bacteremia in an immunosuppressed patient.
Annals of internal medicine 1984;101(1):55-7.